Comparative Analysis of Telehealth and In-Person Consultations for COVID-19 Management

Overview

This study compares the outcomes of telehealth and in-person consultations for managing mild COVID-19 cases in primary care settings. Findings indicate that telehealth may not be as safe as in-person consultations, with implications for future healthcare delivery models.

Background

The COVID-19 pandemic necessitated rapid adaptations in healthcare delivery, including the introduction of telehealth services to manage patient care while minimizing transmission risks. Understanding the effectiveness and safety of telehealth compared to traditional in-person consultations is crucial for optimizing care delivery, especially during infectious disease surges. This study addresses the gap in evidence regarding the comparative safety of telehealth for COVID-19 management.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Telehealth consultations were introduced in Hong Kong to manage mild COVID-19 cases during the pandemic.
• Patients managed via telehealth (Tele-DCs) were compared to those receiving in-person care (PDCs).
• Mixed results were found in existing studies regarding telehealth's effectiveness for COVID-19 management.
• Telehealth may lead to increased rates of emergency department visits and hospitalizations compared to in-person care.
• Robust comparative effectiveness studies are needed to evaluate telehealth's safety for acute respiratory infections.

Clinical Implications

Healthcare providers should consider the potential limitations of telehealth, particularly the inability to perform physical examinations, when managing COVID-19 patients. The findings suggest that in-person consultations may be preferable for certain patient populations to ensure comprehensive care.

Conclusion

This study highlights the need for further research into the safety and effectiveness of telehealth compared to in-person consultations for managing COVID-19. The results may inform future healthcare delivery models in similar infectious disease contexts.

Related Resources & Content

1. Journal of General Internal Medicine, 2022 -- Downstream Healthcare Use Associated with Primary Care In-Person and Telemedicine Visits in 2022
2. Open Forum Infectious Diseases, 2022 -- Evaluating In-person Infectious Disease Care Versus Daily Telemedicine Services at a Community Hospital
3. Pediatric Cardiology, 2022 -- Insights and Perspectives on Telemedicine Utilization in an Adult Congenital Heart Disease Clinic: Key Takeaways from the COVID-19 Crisis
4. The ASCO Post, 2022 -- Looking Back at Telemedicine During the COVID-19 Era: Lessons Learned and Disparities Identified
5. COVID-19 Treatment Clinical Care for Outpatients | Covid | CDC, 2026
6. Episode Charges and Subsequent Visits After Telemedicine vs In-Person Care | Health Policy | JAMA Network, 2026
7. Primary Care Telemedicine vs In-Person Antibiotic Prescribing for Pediatric Respiratory Tract Infections | Pediatrics | JAMA Network, 2026
8. COVID-19 Treatment Clinical Care for Outpatients | Covid | CDC
9. Episode Charges and Subsequent Visits After Telemedicine vs In-Person Care | Health Policy | JAMA Network Open | JAMA Network
10. Primary Care Telemedicine vs In-Person Antibiotic Prescribing for Pediatric Respiratory Tract Infections | Pediatrics | JAMA Network Open | JAMA Network